Literature DB >> 26381230

Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.

Xin Fang1.   

Abstract

Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases with pathophysiology that may be related to the gastrointestinal tract. It is well established that tissue barriers maintain homeostasis and health. Furthermore, gut microbiota may have an impact on brain activity through the gut-microbiota-brain axis under both physiological and pathological conditions. In this review, we highlight the current knowledge regarding the role of gut microbiota and tissue barriers in PD and ALS. To our knowledge, this is the first review of the key issues involving both the altered gut microbiota and impaired tissue barriers in the pathophysiology of PD and ALS.

Entities:  

Keywords:  Parkinson disease; amyotrophic lateral sclerosis; gut microbiota

Mesh:

Year:  2015        PMID: 26381230     DOI: 10.3109/00207454.2015.1096271

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  30 in total

Review 1.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

Review 2.  Communicating systems in the body: how microbiota and microglia cooperate.

Authors:  Daniel Erny; Anna Lena Hrabě de Angelis; Marco Prinz
Journal:  Immunology       Date:  2016-08-24       Impact factor: 7.397

Review 3.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

4.  Effects of Intraoperative Vagal Nerve Stimulation on the Gastrointestinal Microbiome in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Megan M Haney; Aaron C Ericsson; Teresa E Lever
Journal:  Comp Med       Date:  2018-11-13       Impact factor: 0.982

5.  The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.

Authors:  Alba Miranda-Ribera; Gloria Serena; Jundi Liu; Alessio Fasano; Marcy A Kingsbury; Maria R Fiorentino
Journal:  Tissue Barriers       Date:  2021-11-14

6.  Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing.

Authors:  Xin Fang; Xin Wang; Shaoguo Yang; Fanjing Meng; Xiaolei Wang; Hua Wei; Tingtao Chen
Journal:  Front Microbiol       Date:  2016-09-20       Impact factor: 5.640

7.  Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?

Authors:  Bozenna Kuraszkiewicz; Teresa Podsiadły-Marczykowska; Hanna Goszczyńska; Maria Piotrkiewicz
Journal:  Front Neurol       Date:  2018-04-06       Impact factor: 4.003

Review 8.  Advancing human disease research with fish evolutionary mutant models.

Authors:  Emily A Beck; Hope M Healey; Clayton M Small; Mark C Currey; Thomas Desvignes; William A Cresko; John H Postlethwait
Journal:  Trends Genet       Date:  2021-07-29       Impact factor: 11.639

9.  Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer's disease.

Authors:  Wenguang Chang; Junfang Teng
Journal:  Drug Des Devel Ther       Date:  2018-03-05       Impact factor: 4.162

Review 10.  Immune-microbiome interplay and its implications in neurodegenerative disorders.

Authors:  Ankit Uniyal; Vineeta Tiwari; Mousmi Rani; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2021-08-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.